TÜV Hessen

The oral evidence

For expansion with expertise

Vigilant Biosciences is a young, innovative medtech company from the USA that specialises in the early detection of oral cancer. Using a novel method, a rapid test makes it possible to diagnose cancer very easily and accurately at an early stage and to derive appropriate therapeutic measures.

Challenge

The company has already established a certain market presence in the USA, but is still largely unknown among dentists in Europe. The aim here is to generate initial interest and convert this into long-term trust and constant demand.

Solution

Getting to know each other across all channels: with a multimedia launch campaign to introduce the system to the DACH region. And specifically where the primary target group of dentists is: online and offline on relevant channels and at individual events – to promote exchange and bring the brand to life. With resounding success.